Monthly Archives: May 2018

Japanese Yen: Safe Haven Or Inflation Proxy?

In our last commentary on the Japanese yen, we wrote that the currency was looking excessively weak against the euro. In particular, we stated that bullish catalysts driving EUR/JPY were at risk as speculator positioning in both long euro and short yen trades were looking extreme. In addition, we flagged changes to the Bank of Japan’s…

Short-Term Uptrend Is Doing Well

The relative strength of Commodities and Currencies favors higher stock prices. The Short and Medium-Term Trends The short-term uptrend is doing well, and I believe a new medium-term uptrend has started. Breadth indicators continue to support the uptrend. New highs are starting to look healthy, and new lows are at harmless levels. The Bullish Percents…

Nvidia (NVDA) Crushes Q1 Earnings Estimates, Revenue Surges 66%

Nvidia Corporation (NVDA – Free Report) just released its latest quarterly financial results, posting non-GAAP earnings of $2.05 per share and revenues of $3.21 billion. Currently, NVDA is a Zacks Rank #3 (Hold), but that could change based on today’s results. Shares of the company have gained about 13% over the past month, including a 1.7% gain during…

The Ceaseless Ascent

I’d like to off the following off-the-wall musings as a very different take on the market. It’s a disposition that many, many people share, and perhaps it would help me get in sync with the rest of the planet to actually type what everyone else is thinking. I type this to be neither facetious nor…

Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI

Biotechs Underperform and Lag Market Indices on a Good Day-NASDAQ up 0.89% Trading Range Requires Good Stock Picking Skills, XBI is down 0.85% to $89.04. Stealth Buyout with Lilly Acquisition of ARMO BioSciences Biotechs underperformed despite a good opening with the XBI trying to break through the SMA 50 level but fell back around mid-day. Some good news helped…

The 10 Best Dividend Aristocrat Stocks Today

The reason why we are such big fans of the Dividend Aristocrats is simple. Thanks to their strong brands, durable competitive advantages, and steady growth, they have significantly outperformed the broader stock market. Source: Standard & Poor’s Dividend growth stocks are typically viewed as safe, “widow-and-orphan” stocks that should be held for steady dividend income instead…

GLD Update… All Aboard ?

This first chart is a daily line chart for GLD which shows it has completed 5 reversal points so far and is working on the all-important 6th reversal point back up to the top rail. This is where the bulls need to step up to the plate. The weekly chart below shows the 2 1/2 year…